Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 4/20 | 0.38 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.36 |
| ▸ | CLK1 | P49759 | 2/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.36 |
| ▸ | CHUK | O15111 | 1/20 | 0.36 |
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26535943 | 0.95 | LIMK1 (0.38) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL26536007 | 0.94 | LIMK1 (0.40) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL15836077 | 0.87 | LIMK1 (0.38) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL18252193 | 0.86 | MEN1 (0.36) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL25714496 | 0.86 | ALDH1A1 (0.37) | LIMK1ROCK1CLK1PIM3POLB | |
| SCHEMBL18252256 | 0.85 | MEN1 (0.38) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL22373661 | 0.84 | NPC1 (0.43) | LIMK1ROCK1CLK1NPC1POLB | |
| SCHEMBL18252398 | 0.84 | MEN1 (0.34) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL15836036 | 0.83 | LIMK1 (0.38) | LIMK1ROCK1CLK1IKBKBCHUK | |
| SCHEMBL18252332 | 0.83 | MEN1 (0.36) | LIMK1ROCK1IKBKBCHUKPIM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3683217-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | LT Materials Co., Ltd. (KR) | 2020-07-22 | — | — | EP | disclosed |
| US-8952363-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| US-8952363-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-02-10 | — | — | US | disclosed |
| US-20130060037-A1 | MATERIALS WITH AZA-DIBENZOTHIOPHENE OR AZA-DIBENZOFURAN CORE FOR PHOLED | UNIVERSAL DISPLAY CORPORATION (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130060037-A1 | MATERIALS WITH AZA-DIBENZOTHIOPHENE OR AZA-DIBENZOFURAN CORE FOR PHOLED | UNIVERSAL DISPLAY CORPORATION (US) | 2013-03-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130060037-A1 | MATERIALS WITH AZA-DIBENZOTHIOPHENE OR AZA-DIBENZOFURAN CORE FOR PHOLED | DDT, FZD7, BRD7 | LIMK1 3666/4885ROCK1 4861/4885CLK1 4515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.